Free Trial

Catalyst Pharmaceuticals (CPRX) Short Interest Ratio & Short Volume

Catalyst Pharmaceuticals logo
$21.89
+0.09 (+0.41%)
(As of 11/1/2024 ET)

Catalyst Pharmaceuticals Short Interest Data

Catalyst Pharmaceuticals (CPRX) has a short interest of 5.96 million shares, representing 5.82% of the float (the number of shares available for trading by the public). This marks a 3.65% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.1, indicating that it would take 6.1 days of the average trading volume of 1.19 million shares to cover all short positions.

Current Short Interest
5,960,000 shares
Previous Short Interest
5,750,000 shares
Change Vs. Previous Month
+3.65%
Dollar Volume Sold Short
$126.23 million
Short Interest Ratio
6.1 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
118,688,000 shares
Float Size
102,430,000 shares
Short Percent of Float
5.82%
Today's Trading Volume
999,346 shares
Average Trading Volume
1,188,807 shares
Today's Volume Vs. Average
84%
Short Selling Catalyst Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CPRX Short Interest Over Time

CPRX Days to Cover Over Time

CPRX Percentage of Float Shorted Over Time

Catalyst Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20245,960,000 shares $126.23 million +3.7%5.8%6.1 $21.18
9/30/20245,750,000 shares $114.31 million -2.9%5.6%5.8 $19.88
9/15/20245,920,000 shares $119.70 million +2.6%5.8%5.9 $20.22
8/31/20245,770,000 shares $116.84 million +14.3%5.6%5.3 $20.25
8/15/20245,050,000 shares $100.55 million +4.8%4.9%4.5 $19.91
7/31/20244,820,000 shares $83.10 million -9.9%4.7%4.4 $17.24
7/15/20245,350,000 shares $89.61 million +0.9%5.3%4.6 $16.75
6/30/20245,300,000 shares $82.10 million -22.2%5.2%4.4 $15.49
6/15/20246,810,000 shares $102.56 million -6.3%6.7%5.5 $15.06
5/31/20247,270,000 shares $117.56 million -9.0%7.2%6.2 $16.17
5/15/20247,990,000 shares $133.11 million +3.6%7.9%6.1 $16.66
4/30/20247,710,000 shares $116.04 million +23.0%7.6%5.9 $15.05
4/15/20246,270,000 shares $96.50 million +3.6%6.2%4.7 $15.39
3/31/20246,050,000 shares $96.44 million +3.8%6.1%4.1 $15.94
3/15/20245,830,000 shares $93.69 million -9.9%5.8%3.9 $16.07
2/29/20246,470,000 shares $103.71 million +14.1%6.5%4.3 $16.03
2/15/20245,670,000 shares $78.76 million +20.9%6.2%4.1 $13.89
1/31/20244,690,000 shares $67.54 million -21.3%5.1%3.3 $14.40
1/15/20245,960,000 shares $86.36 million +5.9%6.5%4 $14.49
12/31/20235,630,000 shares $94.64 million -21.6%6.1%4 $16.81
12/15/20237,180,000 shares $103.25 million +4.7%7.9%5.8 $14.38
11/30/20236,860,000 shares $98.99 million +3.0%7.5%5.7 $14.43
11/15/20236,660,000 shares $90.91 million +3.7%7.3%5.5 $13.65
10/31/20236,420,000 shares $79.67 million +2.4%7.0%5.2 $12.41
10/15/20236,270,000 shares $80.13 million -1.3%6.8%5.2 $12.78
9/30/20236,350,000 shares $74.23 million -20.0%6.9%5.2 $11.69
9/15/20237,940,000 shares $98.93 million +10.9%8.7%6.2 $12.46
8/31/20237,160,000 shares $100.53 million +6.1%7.2%4.7 $14.04
8/15/20236,750,000 shares $101.12 million +2.4%6.8%4.2 $14.98
7/31/20236,590,000 shares $91.14 million -8.3%6.6%3.5 $13.83
7/15/20237,190,000 shares $92.46 million -9.1%7.2%3.7 $12.86
6/30/20237,910,000 shares $106.31 million -6.2%8.0%4 $13.44
6/15/20238,430,000 shares $104.28 million -8.0%8.5%4.3 $12.37
5/31/20239,160,000 shares $105.80 million -3.5%9.2%4.7 $11.55
5/15/20239,490,000 shares $124.70 million -15.2%9.6%4.9 $13.14
4/30/202311,190,000 shares $178.14 million +2.2%11.2%6.5 $15.92
4/15/202310,950,000 shares $193.71 million -3.4%11.0%5 $17.69
3/31/202311,330,000 shares $187.85 million +15.9%11.4%5 $16.58
3/15/20239,780,000 shares $140.25 million -5.7%9.9%4.1 $14.34
2/28/202310,370,000 shares $158.25 million +6.5%10.6%4.4 $15.26
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

2/15/20239,740,000 shares $149.61 million +12.9%10.0%3.8 $15.36
1/31/20238,630,000 shares $133.68 million -15.3%8.8%3.1 $15.49
1/15/202310,190,000 shares $214.50 million -3.0%10.4%3.9 $21.05
12/30/202210,510,000 shares $195.49 million +38.8%10.8%4.7 $18.60
12/15/20227,570,000 shares $127.48 million -4.2%7.7%3.2 $16.84
11/30/20227,900,000 shares $132.48 million +18.4%8.1%2.5 $16.77
11/15/20226,670,000 shares $105.99 million -17.3%6.8%2 $15.89
10/31/20228,060,000 shares $111.79 million -7.6%8.4%2.5 $13.87
10/15/20228,720,000 shares $109.44 million -3.8%9.0%2.7 $12.55
9/30/20229,060,000 shares $116.24 million +82.3%9.4%2.7 $12.83
9/15/20224,970,000 shares $67.69 million -20.1%5.2%1.5 $13.62
8/31/20226,220,000 shares $84.22 million -8.4%6.6%2.9 $13.54
8/15/20226,790,000 shares $96.62 million -3.7%7.2%3.7 $14.23
7/31/20227,050,000 shares $72.19 million -20.3%7.4%4.5 $10.24
7/15/20228,840,000 shares $75.76 million -13.3%9.3%6.2 $8.57
6/30/202210,190,000 shares $71.43 million +4.3%10.7%8.8 $7.01
6/15/20229,770,000 shares $63.60 million +11.0%10.3%8.4 $6.51
5/31/20228,800,000 shares $63.36 million +18.1%9.3%7.8 $7.20
5/15/20227,450,000 shares $51.48 million +45.8%7.8%6.4 $6.91
4/30/20225,110,000 shares $38.94 million +10.6%5.4%4.3 $7.62
4/15/20224,620,000 shares $38.85 million +1.1%4.9%4 $8.41
3/31/20224,570,000 shares $37.89 million -3.8%4.8%3.9 $8.29
3/15/20224,750,000 shares $35.82 million -9.7%5.0%4.2 $7.54
2/28/20225,260,000 shares $41.03 million +2.7%5.5%4.6 $7.80
2/15/20225,120,000 shares $39.53 million +18.2%5.4%4.6 $7.72
1/31/20224,330,000 shares $24.94 million +13.7%4.5%4 $5.76
1/15/20223,810,000 shares $23.77 million +6.1%N/A3.9 $6.24
12/31/20213,590,000 shares $24.30 million -15.1%3.8%3.9 $6.77
12/15/20214,230,000 shares $29.27 million +3.9%4.4%4.1 $6.92
11/30/20214,070,000 shares $28.49 million -2.4%4.3%4.6 $7.00
11/15/20214,170,000 shares $30.44 million -2.1%4.4%4.7 $7.30
10/29/20214,260,000 shares $25.13 million -3.4%4.5%5.1 $5.90
10/15/20214,410,000 shares $26.59 million -7.0%4.6%5.3 $6.03
9/30/20214,740,000 shares $25.12 million -9.2%5.0%5.5 $5.30
9/15/20215,220,000 shares $26.10 million -0.8%5.5%6.1 $5.00
8/31/20215,260,000 shares $28.98 million -7.4%5.5%5.5 $5.51
8/13/20215,680,000 shares $34.31 million -2.1%5.9%5.7 $6.04
7/30/20215,800,000 shares $33.87 million +1.9%6.0%5.2 $5.84
7/15/20215,690,000 shares $31.41 million -11.8%5.9%4.8 $5.52
6/30/20216,450,000 shares $37.09 million -30.2%6.7%5.2 $5.75
6/15/20219,240,000 shares $52.48 million -3.8%9.6%7.5 $5.68
5/28/20219,600,000 shares $53.09 million -9.9%10.0%7.1 $5.53
5/14/202110,660,000 shares $53.09 million -2.0%11.1%7.3 $4.98
4/30/202110,880,000 shares $51.68 million -7.1%11.3%7.2 $4.75
4/15/202111,710,000 shares $52.23 million -5.3%12.1%7 $4.46
3/31/202112,370,000 shares $53.69 million +29.5%12.8%7 $4.34
3/15/20219,550,000 shares $37.15 million +13.7%9.9%4.9 $3.89
2/26/20218,400,000 shares $32.76 million -8.8%8.7%4.5 $3.90
2/12/20219,210,000 shares $39.83 million -6.6%9.6%4.9 $4.33
1/29/20219,860,000 shares $35.50 million -2.7%10.2%5.3 $3.60
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

1/15/202110,130,000 shares $35.76 million -0.3%10.5%6 $3.53
12/31/202010,160,000 shares $34.75 million -17.3%10.5%6.3 $3.42
12/15/202012,280,000 shares $47.03 million -4.2%12.7%7.4 $3.83
11/30/202012,820,000 shares $47.43 million -4.6%13.3%8.4 $3.70
11/15/202013,440,000 shares $45.70 million +0.1%13.9%8.8 $3.40
10/30/202013,430,000 shares $41.77 million +4.9%13.9%7.9 $3.11
10/15/202012,800,000 shares $40.83 million -6.2%13.3%6.6 $3.19
9/30/202013,640,000 shares $40.51 million +17.2%14.2%6.9 $2.97
9/15/202011,640,000 shares $39.11 million -7.4%12.1%6.2 $3.36
8/31/202012,570,000 shares $41.23 million +2.0%13.1%6.3 $3.28
8/14/202012,330,000 shares $42.79 million +7.0%12.8%6.1 $3.47
7/31/202011,520,000 shares $49.54 million -1.1%12.0%6.1 $4.30
7/15/202011,650,000 shares $57.78 million -3.6%12.1%6.8 $4.96
6/30/202012,090,000 shares $55.86 million -13.0%12.6%6.6 $4.62
6/15/202013,890,000 shares $60.98 million +8.5%14.4%7.2 $4.39
5/29/202012,800,000 shares $55.17 million -2.0%13.3%6.2 $4.31
5/15/202013,060,000 shares $55.64 million +7.0%13.6%6.1 $4.26
4/30/202012,210,000 shares $57.88 million -12.9%12.7%5.8 $4.74
4/15/202014,010,000 shares $60.94 million +1.4%14.6%6.7 $4.35
3/31/202013,820,000 shares $69.38 million -1.5%14.4%6.4 $5.02
3/13/202014,028,300 shares $61.86 million +13.0%14.7%7.3 $4.41
2/28/202012,420,000 shares $38.87 million +1.1%13.0%5.7 $3.13
2/14/202012,290,000 shares $46.82 million -3.2%12.8%5.5 $3.81
1/31/202012,690,000 shares $59.14 million +12.1%13.3%5.4 $4.66
1/15/202011,320,000 shares $51.96 million -4.3%11.8%4.7 $4.59
12/31/201911,830,000 shares $47.08 million +32.9%12.4%5 $3.98

CPRX Short Interest - Frequently Asked Questions

What is Catalyst Pharmaceuticals' current short interest?

Short interest is the volume of Catalyst Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 5,960,000 shares of CPRX short. 5.82% of Catalyst Pharmaceuticals' shares are currently sold short. Learn More on Catalyst Pharmaceuticals' current short interest.

What is a good short interest ratio for Catalyst Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CPRX shares currently have a short interest ratio of 6.0. Learn More on Catalyst Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Catalyst Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.82% of Catalyst Pharmaceuticals' floating shares are currently sold short.

Is Catalyst Pharmaceuticals' short interest increasing or decreasing?

Catalyst Pharmaceuticals saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 5,960,000 shares, an increase of 3.7% from the previous total of 5,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Catalyst Pharmaceuticals' float size?

Catalyst Pharmaceuticals currently has issued a total of 118,688,000 shares. Some of Catalyst Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Catalyst Pharmaceuticals currently has a public float of 102,430,000 shares.

How does Catalyst Pharmaceuticals' short interest compare to its competitors?

5.82% of Catalyst Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Catalyst Pharmaceuticals: IDEAYA Biosciences, Inc. (12.55%), ANI Pharmaceuticals, Inc. (9.74%), Cue Biopharma, Inc. (4.01%), Syros Pharmaceuticals, Inc. (4.82%), DURECT Co. (3.30%), Qiagen (1.77%), Roivant Sciences Ltd. (13.34%), Revolution Medicines, Inc. (9.97%), Legend Biotech Co. (6.56%), Intra-Cellular Therapies, Inc. (2.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Catalyst Pharmaceuticals stock?

Short selling CPRX is an investing strategy that aims to generate trading profit from Catalyst Pharmaceuticals as its price is falling. CPRX shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Catalyst Pharmaceuticals?

A short squeeze for Catalyst Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CPRX, which in turn drives the price of the stock up even further.

How often is Catalyst Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPRX, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:CPRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners